Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Accounting Officer

Chief Operating Officer

Chief Regulatory Officer

Chief Legal Officer

Chief Medical Officer

Chief Scientific Officer

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease and other related synucleinopathies; NNC6019 that completed Phase I clinical trial for the treatment of ATTR amyloidosis; and PRX005, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its discovery and preclinical programs include PRX012 for the treatment of Alzheimer's disease; and PRX123, a dual AÃƒÅ¸-Tau vaccine for the treatment and prevention of Alzheimer's disease, as well as TDP-43 and PRX019 for the treatment of Alzheimer's disease and other neurodegenerative diseases. Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein, including prasinezumab; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. The company was founded in 2012 and is based in Dublin, Ireland.

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies to treat diseases caused ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-24	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-01-24	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-12-20	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2023-12-20	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-11-30	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2023-11-30	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-10-25	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2023-10-25	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-10-11	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-10-11	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2023-10-04	Premium	sold	Premium	Premium	Premium	Chief Regulatory Officer
2023-10-04	Premium	acquired	Premium	Premium	Premium	Chief Regulatory Officer
2023-09-27	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-09-27	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-09-19	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-09-19	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2023-09-13	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-09-13	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-09-13	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2023-09-13	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-09-06	Premium	acquired	Premium	Premium	Premium	Chief Regulatory Officer
2023-09-06	Premium	sold	Premium	Premium	Premium	Chief Regulatory Officer
2023-08-30	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-08-30	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-08-18	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer

PRTA - Prothena Corp PLC Stock Price, Fair Value and News

Latest Insider Trading transactions for PRTA